TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 49 positions · Total reported value $3.50B · Top-10 concentration 60.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 7 new · 15 cut · 5 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.6% · vs SPY -9.8% · Prev Value $4.16B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.9% · vs SPY -5.0% · Latest Value $3.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, TCG Crossover Management, LLC disclosed 49 equity positions with a combined reported value of $3.50B. The filing implies a focused portfolio: its ten largest positions account for 60.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were ABVX ($721.67M), CGON ($248.40M), TNGX ($220.31M). By sector, the heaviest allocations are Health Care 95.1%, Other 4.9%. Versus the prior quarter, allocation shifted toward Health Care (+3.8pp) and away from Other (-1.7pp), Industrials (-2.2pp).

Versus the prior quarter, TCG Crossover Management, LLC opened 7 new positions, trimmed 15 and fully exited 5, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q1 2026 were BCRX ($104.92M), VOR ($96.50M), IRON ($85.80M).

Of the 5 positions fully exited versus the prior quarter, the largest were RAPT ($87.47M), EYPT ($65.27M), AGIO ($32.17M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • BCRX BIOCRYST PHARMACEUTICALS INC · $104.92M
  • VOR VOR BIOPHARMA INC · $96.50M
  • IRON DISC MEDICINE INC · $85.80M
  • SRZN SURROZEN INC · $42.91M
  • IPSC CENTURY THERAPEUTICS INC · $39.02M
  • TECX TECTONIC THERAPEUTIC INC · $37.24M
  • CATX PERSPECTIVE THERAPEUTICS INC · $33.01M
  • ALXO ALX ONCOLOGY HLDGS INC · $26.09M

Fully Exited (vs previous quarter)

  • RAPT RAPT THERAPEUTICS INC · prev qtr: $87.47M
  • EYPT EYEPOINT INC · prev qtr: $65.27M
  • AGIO AGIOS PHARMACEUTICALS INC · prev qtr: $32.17M
  • MAZE MAZE THERAPEUTICS INC · prev qtr: $7.20M
  • VTYX VENTYX BIOSCIENCES INC · prev qtr: $2.86M

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 95.1%
Other 4.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.48M $721.67M 20.65%
20.65%
Reduce
2 3.67M $248.40M 7.11%
7.11%
Hold
3 10.53M $220.31M 6.30%
6.30%
Reduce
4 4.95M $190.41M 5.45%
5.45%
Reduce
5 4.29M $170.26M 4.87%
4.87%
Hold
6 1.68M $140.70M 4.03%
4.03%
Hold
7 3.25M $124.44M 3.56%
3.56%
Add
8 4.46M $110.74M 3.17%
3.17%
Add
9 11.02M $104.92M 3.00%
3.00%
New
10 1.06M $98.11M 2.81%
2.81%
Add
11 5.67M $96.50M 2.76%
2.76%
New
12 1.90M $95.87M 2.74%
2.74%
Hold
13 6.24M $86.79M 2.48%
2.48%
Hold
14 1.34M $85.80M 2.46%
2.46%
New
15 4.62M $83.67M 2.39%
2.39%
Hold
16 4.62M $76.03M 2.17%
2.17%
Hold
17 12.36M $67.50M 1.93%
1.93%
Hold
18 576.47K $56.06M 1.60%
1.60%
Add
19 1.45M $55.10M 1.58%
1.58%
Hold
20 1.84M $45.28M 1.29%
1.29%
Add
21 1.47M $42.91M 1.23%
1.23%
New
22 11.39M $42.71M 1.22%
1.22%
Hold
23 4.27M $42.52M 1.22%
1.22%
Add
24 5.25M $40.27M 1.15%
1.15%
Hold
25 4.63M $39.18M 1.12%
1.12%
Hold
26 17.75M $39.02M 1.12%
1.12%
New
27 1.20M $37.24M 1.06%
1.06%
New
28 7.92M $33.01M 0.94%
0.94%
New
29 2.45M $29.57M 0.85%
0.85%
Hold
30 2.29M $28.87M 0.83%
0.83%
Add
31 13.01M $26.09M 0.75%
0.75%
New
32 2.39M $25.31M 0.72%
0.72%
Reduce
33 1.79M $24.88M 0.71%
0.71%
Hold
34 2.05M $21.54M 0.62%
0.62%
New
35 10.00M $21.50M 0.61%
0.61%
Hold
36 650.00K $19.40M 0.56%
0.56%
Hold
37 3.03M $15.99M 0.46%
0.46%
Hold
38 403.05K $15.21M 0.43%
0.43%
Reduce
39 1.65M $13.96M 0.40%
0.40%
Reduce
40 738.38K $11.02M 0.32%
0.32%
Add
41 405.37K $7.29M 0.21%
0.21%
Reduce
42 132.10K $7.24M 0.21%
0.21%
Reduce
43 2.68M $7.03M 0.20%
0.20%
New
44 140.41K $6.77M 0.19%
0.19%
Reduce
45 406.79K $5.78M 0.17%
0.17%
New
46 416.30K $4.71M 0.14%
0.14%
Hold
47 464.40K $4.67M 0.13%
0.13%
Hold
48 181.06K $1.63M 0.05%
0.05%
Reduce
49 2.68M $1.53M 0.04%
0.04%
Hold

FAQ

What did TCG Crossover Management, LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, TCG Crossover Management, LLC reported 49 equity positions worth $3.50B in aggregate; its largest disclosed positions were ABVX ($721.67M), CGON ($248.40M), TNGX ($220.31M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $3.50B of long equity holdings across 49 positions as of 2026-Q1. Top-10 holdings account for 60.9% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →